Design Therapeutics, Inc. Common Stock

DSGN

...

DSGN: Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations.

Show DSGN Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of DSGN by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by DSGN's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on DSGN's company Twitter account

WallStreetBets

Number of mentions of DSGN in WallStreetBets Daily Discussion

DSGN News

Recent insights relating to DSGN

CNBC Recommendations

Recent picks made for DSGN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in DSGN

Corporate Flights

Flights by private jets registered to DSGN